GlaxoSmithKline PLC
06 January 2004
Directors' Interests
I give below details of changes in the directors' interests in the Ordinary
Shares and ADS Shares of GlaxoSmithKline plc.
On 31 December 2003, the following Non-Executive Directors were provisionally
allocated the following awards over Ordinary Shares and American Depository
Shares (ADS's) in the Company through the Annual Re-investment of Dividends paid
throughout 2003, as listed below:
SmithKline Beecham Non-Executive Directors Retainer Fee and Share Allocation
Award - Annual Dividend Reinvestment
Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price ($)
Shares
Sir Christopher Hogg 30.077 12.76
Mr D McHenry 13.155 46.183
Sir Ian Prosser 30.077 12.76
Dr Lucy Shapiro 48.871 12.76 13.155 46.183
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share
Award - Annual Dividend Reinvestment
Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price ($)
Shares
Sir Christopher Hogg 327.877 12.76
Dr Michele Barzach 67.265 12.76
Sir Peter Job 245.375 12.76
Mr J McArthur 43.635 46.183
Mr D McHenry 29.440 46.183
Sir Ian Prosser 157.948 12.76
Dr Ronaldo Schmitz 153.805 12.76
Dr Lucy Shapiro 29.440 46.183
The Company was notified of this information on 5th January 2003.
S M Bicknell
Company Secretary
6th January 2004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.